Table 3:
Subtype/CRF | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Characteristic | Only B n (%) |
A1 n (%) |
C n (%) |
D n (%) |
G n (%) |
CRF01_AE n (%) |
CRF02_AG n (%) |
CRF07_BC n (%) |
Other CRF n (%) |
Total non-B n (%) |
Total n (%) |
Sex at Birth | |||||||||||
Female | 634 (9.0) | 4 (44.4) | 14 (42.4) | 2 (50.0) | 3 (60.0) | 2 (3.7) | 5 (29.4) | 3 (30.0) | 1 (11.1) | 34 (24.1) | 668 (9.3) |
Male | 6,382 (91.0) | 5 (55.6) | 19 (57.6) | 2 (50.0) | 2 (40.0) | 52 (96.3) | 12 (70.6) | 7 (70.0) | 8 (88.9) | 107 (75.9) | 6,489 (90.7) |
Race/Ethnicity | |||||||||||
Asian/Pacific Islander | 337 (4.8) | 4 (44.4) | 9 (27.3) | 2 (50.0) | 0 (0.0) | 33 (61.1) | 3 (17.6) | 10 (100.0) | 1 (11.1) | 62 (44.0) | 399 (5.6) |
Black, not Hispanic | 1,432 (20.4) | 1 (11.1) | 14 (42.4) | 1 (25.0) | 4 (80.0) | 2 (3.7) | 9 (52.9) | 0 (0.0) | 1 (11.1) | 32 (22.7) | 1,464 (20.5) |
Hispanic | 1,593 (22.7) | 1 (11.1) | 2 (6.1) | 0 (0.0) | 0 (0.0) | 5 (9.3) | 0 (0.0) | 0 (0.0) | 1 (11.1) | 9 (6.4) | 1,602 (22.4) |
White, not Hispanic | 3,333 (47.5) | 3 (33.3) | 7 (21.2) | 0 (0.0) | 1 (20.0) | 12 (22.2) | 4 (23.5) | 0 (0.0) | 5 (55.6) | 32 (22.7) | 3,365 (47.0) |
Other/Unknown | 321 (4.6) | 0 (0.0) | 1 (3.0) | 1 (25.0) | 0 (0.0) | 2 (3.7) | 1 (5.9) | 0 (0.0) | 1 (11.1) | 6 (4.3) | 327 (4.6) |
Country of Birth | |||||||||||
USA | 5,446 (77.6) | 3 (33.3) | 7 (21.2) | 1 (25.0) | 4 (80.0) | 14 (25.9) | 8 (47.1) | 1 (10.0) | 3 (33.3) | 41 (29.1) | 5,487 (76.7) |
Non-USA | 1,032 (14.7) | 6 (66.7) | 22 (66.7) | 3 (75.0) | 1 (20.0) | 31 (57.4) | 6 (35.3) | 9 (90.0) | 4 (44.4) | 82 (58.2) | 1,114 (15.6) |
Unknown | 538 (7.7) | 0 (0.0) | 4 (12.1) | 0 (0.0) | 0 (0.0) | 9 (16.7) | 3 (17.6) | 0 (0.0) | 2 (22.2) | 18 (12.8) | 556 (7.8) |
Transmission Risk | |||||||||||
Heterosexual sex | 342 (4.9) | 5 (55.6) | 13 (39.4) | 1 (25.0) | 2 (40.0) | 7 (13.0) | 4 (23.5) | 5 (50.0) | 1 (11.1) | 38 (27.0) | 380 (5.3) |
Injection drug use | 813 (11.6) | 0 (0.0) | 3 (9.1) | 0 (0.0) | 2 (40.0) | 2 (3.7) | 3 (17.6) | 1 (10.0) | 0 (0.0) | 11 (7.8) | 824 (11.5) |
Male sex with men | 4,058 (57.8) | 4 (44.4) | 9 (27.3) | 1 (25.0) | 1 (20.0) | 42 (77.8) | 8 (47.1) | 3 (30.0) | 8 (88.9) | 76 (53.9) | 4,134 (57.8) |
Both injection drug use & male sex with men | 1,690 (24.1) | 0 (0.0) | 2 (6.1) | 1 (25.0) | 0 (0.0) | 2 (3.7) | 1 (5.9) | 0 (0.0) | 0 (0.0) | 6 (4.3) | 1,696 (23.7) |
Other/unknown | 113 (1.6) | 0 (0.0) | 6 (18.2) | 1 (25.0) | 0 (0.0) | 1 (1.9) | 1 (5.9) | 1 (10.0) | 0 (0.0) | 10 (7.1) | 123 (1.7) |
Age at HIV Diagnosis | |||||||||||
Under 25 years old | 1,010 (14.4) | 4 (44.4) | 2 (6.1) | 2 (50.0) | 0 (0.0) | 11 (20.4) | 4 (23.5) | 1 (10.0) | 2 (22.2) | 26 (18.4) | 1,036 (14.5) |
25-29 years old | 1,316 (18.8) | 2 (22.2) | 6 (18.2) | 0 (0.0) | 1 (20.0) | 12 (22.2) | 4 (23.5) | 0 (0.0) | 1 (11.1) | 26 (18.4) | 1,342 (18.8) |
30-39 years old | 2,731 (38.9) | 0 (0.0) | 8 (24.2) | 2 (50.0) | 0 (0.0) | 12 (22.2) | 4 (23.5) | 4 (40.0) | 5 (55.6) | 35 (24.8) | 2,766 (38.6) |
40-49 years old | 1,488 (21.2) | 2 (22.2) | 12 (36.4) | 0 (0.0) | 4 (80.0) | 14 (25.9) | 4 (23.5) | 3 (30.0) | 0 (0.0) | 39 (27.7) | 1,527 (21.3) |
50 years old or older | 469 (6.7) | 1 (11.1) | 4 (12.1) | 0 (0.0) | 0 (0.0) | 5 (9.3) | 1 (5.9) | 2 (20.0) | 1 (11.1) | 14 (9.9) | 483 (6.7) |
Unknown | 2 (0.0) | 0 (0.0) | 1 (3.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (0.7) | 3 (0.0) |
Year of HIV Diagnosis | |||||||||||
Before 1990 | 447 (6.4) | 0 (0.0) | 1 (3.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (0.7) | 448 (6.3) |
1990-1999 | 2,192 (31.2) | 0 (0.0) | 2 (6.1) | 0 (0.0) | 2 (40.0) | 2 (3.7) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 6 (4.3) | 2,198 (30.7) |
2000-2009 | 2,813 (40.1) | 4 (44.4) | 13 (39.4) | 2 (50.0) | 2 (40.0) | 11 (20.4) | 6 (35.3) | 2 (20.0) | 1 (11.1) | 41 (29.1) | 2,854 (39.9) |
2010-2016 | 1,564 (22.3) | 5 (55.6) | 17 (51.5) | 2 (50.0) | 1 (20.0) | 41 (75.9) | 11 (64.7) | 8 (80.0) | 8 (88.9) | 93 (66.0) | 1,657 (23.2) |
TOTAL | 7,016 (100.0) | 9 (100.0) | 33 (100.0) | 4 (100.0) | 5 (100.0) | 54 (100.0) | 17 (100.0) | 10 (100.0) | 9 (100.0) | 141 (100.0) | 7,157 (100.0) |